Curis (CRIS) CUDC-305 Data Published in Molecular Cancer Therapeutics
Tweet Send to a Friend
Curis, Inc. (NASDAQ: CRIS) today announced that preclinical data related to CUDC-305, the company's Heat Shock Protein (HSP) 90 inhibitor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
